Great to see they adding more person for R&D
I wish after Atomo able to broaden they product range (e.g digital platforms etc)
Atomo will be no longer an simple medical device company. They will be more like company offering “solutions” on product design and enhancement. Big bio will view Atomo as a go to place for they product design problem, saving them huge investment on R&D.
My wishful thinking
Great to see they adding more person for R&DI wish after Atomo...
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $4.355K | 222.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1968855 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 416397 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |